Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract??? Sperm chromatin incubated in Xenopus egg extracts undergoes origin licensing and nuclear assembly before DNA replication. We found that depletion of DNA topoisomerase IIα (topo IIα), the sole topo II isozyme of eggs and its inhibition by ICRF-193, which clamps topo IIα around DNA have opposite effects on these processes. ICRF-193 slowed down replication origin cluster activation and fork progression in a checkpoint-independent manner, without altering replicon size. In contrast, topo IIα depletion accelerated origin cluster activation, and topo IIα add-back negated overinitiation. Therefore, topo IIα is not required for DNA replication, but topo IIα clamps slow replication, probably by forming roadblocks. ICRF-193 had no effect on DNA synthesis when added after nuclear assembly, confirming that topo IIα activity is dispensable for replication and revealing that topo IIα clamps formed on replicating DNA do not block replication, presumably because topo IIα acts behind and not in front of forks. Topo IIα depletion increased, and topo IIα addition reduced, chromatin loading of MCM2-7 replicative helicase, whereas ICRF-193 did not affect MCM2-7 loading. Therefore, topo IIα restrains MCM2-7 loading in an ICRF-193-resistant manner during origin licensing, suggesting a model for establishing the sequential firing of origin clusters.
Figure 1. Concentration- and time-of-addition-dependent effects of ICRF-193 on DNA replication in egg extracts. (A) Kinetoplast DNA decatenation activity of egg extract in the presence of 100 µM ICRF-193, or in the presence of the drug solvent (DMSO) alone, was assessed at the indicated times. Input (1) and decatenated (2) DNA molecules are indicated. (B) Same experiment as in (A), but in the presence of 10 µM ICRF-193. (C) Sperm nuclei were incubated in egg extract in the presence of DMSO or 100 µM ICRF-193, added at 0 min or at 20 min. Replication was monitored by [α-32P]-dATP incorporation. (D) Same experiment as in C but using 10 µM ICRF-193. (E) Percentage of replication in the presence of 100 µM ICRF-193 added at 0 min plotted against the control. Data are from 14 independent experiments. (F) Same as in (E), but ICRF-193 was added at 20 min. Data are from six independent experiments. (G) Sperm nuclei were incubated in egg extract in the presence or absence of 100 µM ICRF-193 added at the times indicated by the symbols in the insert. The percentage of replication in the presence of the drug is plotted against the control.
Figure 2. Time-of-addition-dependent effects of ICRF-193 on nuclear structure and replication foci. (A) Sperm nuclei were incubated in egg extract in the presence of 20 µM rhodaminâdUTP and either drug solvent alone (DMSO) or 100 µM ICRF-193 added at 0 min. Reactions were stopped at the indicated times, fixed and stained with Hoechst. Replication foci were imaged as described in the âMaterials and Methodsâ section. Scale bar = 5 µm. (B) Mean and standard deviation (n = 30) of the number of replication foci per nucleus at 20 min and 30 min with or without ICRF-193. (C) Mean ± SD (n = 50) of nuclear area at 30, 45 and 60 min with DMSO or ICRF-193 added at 0 or 20 min. (D) Replication run-on assay. Sperm nuclei in egg extracts were pulsed for 5 min with rhodaminâdUTP at 40 or 90 min, fixed and stained with Hoechst. (E) Percentage of replicating nuclei at 40 or 90 min in the experiment shown in (D). In all, 150â200 nuclei were counted per sample.
Figure 3. Alkaline gel electrophoretic analysis of ICRF-193-induced perturbation of DNA synthesis. (A) ICRF-193 added at 0 min, but not 20 min, reduces the abundance and perturbs the growth of nascent DNA strands. Sperm nuclei were incubated in egg extract containing [α-32P]-dATP in the presence of DMSO or 100 µM ICRF-193, added at 0 or at 20 min. Nascent strand abundance and growth was monitored by alkaline gel electrophoresis at the indicated time points. (B) Phosphorimager scan profiles of the 40 min lanes in (A). (C) Pulse-chase analysis of nascent strand growth. Sperm nuclei incubated in egg extract in the presence of DMSO or ICRF-193 added at 0 min or 20 min as indicated were labeled at 28 min with a 2 min pulse of [α-32P]dATP and chased for the indicated times with unlabeled dATP in the presence of roscovitin. Nascent strands were analyzed as in (A). (D) Nascent strand maturation analysis. Same experiment as in (A) except for the indicated times.
Figure 4. DNA combing analysis of ICRF-193-induced perturbation of DNA synthesis. Sperm nuclei were incubated in egg extract plus biotinâdUTP for 35 or 45 min. DNA was extracted, combed on silanized coverslips and biotin-labeled replication eyes and total DNA were revealed using red and green fluorochrome-conjugated antibodies, respectively. (A) An exemplary DNA fiber visualized in the two channels and a merge picture. The midpoints of consecutive eyes are indicated by vertical white arrows. The distance between two consecutive arrows is referred to as eye-to-eye distance (ETED). (B) Representative single DNA molecules from the indicated samples and interpretative diagrams. Scale bar, 10 kb. Total replication extent (C), mean eye length (D), total fork density (E), intercluster distances (F) and distributions of ETED (size bins indicated in kb below horizontal axis) at 35 (G) and 45 min (H) were measured for each condition as described in the text.
Figure 5. Effects of topo IIα depletion and addition on DNA replication kinetics and nuclear structure. (A and B) Topo IIα immunodepletion. Mock-depleted and topo IIα-depleted extracts were analyzed by western blotting with an anti-Xtopo IIα antibody (A; volume of extracts are indicated) and by kDNA decatenation (B). (C) Sperm nuclei were incubated in mock-depleted or topoIIα-depleted extracts containing [α-32P]-dATP plus or minus 100 µM ICRF-193 for 60 min, and the ratio of replicated DNA with and without ICRF-193 was calculated. (D) Sperm nuclei were incubated in mock-depleted (dotted lines) or topo IIα-depleted (solid lines) extracts containing [α-32P]-dATP supplemented with buffer (circles) or with recombinant human topo IIα (squares), and replication efficiency was measured at the indicated times. (E) Sperm nuclei were incubated in mock-depleted (upper panels) or topo IIα-depleted (lower panels) extracts in the presence of rhodaminâdUTP for 90 min, fixed and stained with Hoechst and observed under a fluorescence microscope. Scale bar, 2.5 µm. (F) Sperm nuclei were incubated in extracts containing [α-32P]-dATP supplemented with buffer (circles) or with recombinant human topo IIα (squares) added at 0 min, and replication was measured at the indicated times. (G) Same as in (F), except that buffer or topo IIα were added at 20 min.
Figure 6. Gel electrophoretic and DNA combing analysis of replication intermediates synthesized in mock- and topoIIα-depleted extracts. (A) Pulse-chase analysis of nascent strand growth. Sperm nuclei incubated in mock- or topoIIα-depleted extracts were labeled at 50 min with a 10-min pulse of [α-32P]dATP and chased for the indicated times with unlabeled dATP in the presence of roscovitin. Nascent strands were electrophoresed in an alkaline agarose gel as in Figure 3A. (BâH) DNA combing analysis. Sperm nuclei were incubated in egg extract plus biotinâdUTP for 85, 105 or 115 min. DNA was extracted and combed as described in Figure 4. Total replication extent (B), total fork density (C), overall eye length (D) and mean intrafiber eye-to-eye distances (E) are shown for the three time points. To compare replication patterns within clusters, fibers subsets of comparable replication extents were selected and intrafiber eye lengths (F) and eye-to-eye distances (G) were measured. (H) Representative single DNA molecules from the indicated time samples and interpretative diagrams. Scale bar, 10 kb.
Figure 7. Effects of topo IIα depletion (A and B) or addition (C and D) on chromatin binding of MCM3, MCM7, RecQ4, Cdc45 and topo IIα. Sperm nuclei were incubated in mock-depleted (A, dotted lines), topo IIα-depleted (A, solid lines) or undepleted (C) extracts added with recombinant htopo IIα (C, dark gray lines) or htopo IIα dilution buffer (C, light gray lines). (A and C) Purified chromatin at indicated times was analyzed by western blotting for the indicated proteins. Histone H3 was used as a loading control. Samples without egg extract (E-) or without sperm nuclei (S-) and 3 µl of unprocessed extract (E) were loaded as internal controls. The inset shown in (C) illustrates the electrophoretic resolution of human and Xenopus topo IIα. The signals quantified using Image J and normalized to histone H3 are shown as graphs. (B and D) Quantitation of MCM loading over multiple experiments and time points. Shown is the average ratio ± S.E.M of MCM signal (normalized to histone H3), in topo IIα-depleted (B) or htopo IIα-added (D) extracts, to MCM signal in control extracts. The observed ratios are significantly (****P < 0.10â4) different from the expected value of 1 in the null hypothesis, as indicated by asterisks and dotted lines.
Figure 8. Effects of topo IIα inhibition by ICRF-193 on chromatin binding of MCM3, MCM7, RecQ4 and topo IIα. Sperm nuclei were incubated in undepleted extracts added with DMSO or 100 µM ICRF-193 at 0 or 20 min. (A) Purified chromatin at indicated times was analyzed by western blotting for the indicated proteins. Histone H3 was used as a loading control. Samples without egg extract (E-) or without sperm nuclei (S-) and 3 µl of unprocessed extract (E) were loaded as internal controls. (B) The signals quantified using Image J and normalized to histone H3 are shown as graphs. (C) Quantitation of MCM loading over multiple experiments and time points. Shown is the average ratio ± SEM of MCM signal (normalized to histone H3) in ICRF-193-treated extracts to MCM signal in control extracts. The observed ratios are not significantly different from the expected value of 1 in the null hypothesis.
Abdurashidova,
Functional interactions of DNA topoisomerases with a human replication origin.
2007, Pubmed
Abdurashidova,
Functional interactions of DNA topoisomerases with a human replication origin.
2007,
Pubmed
Adachi,
Chromosome assembly in vitro: topoisomerase II is required for condensation.
1991,
Pubmed
,
Xenbase
Bartek,
Checking on DNA damage in S phase.
2004,
Pubmed
Baxter,
Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast.
2008,
Pubmed
Bermejo,
Top1- and Top2-mediated topological transitions at replication forks ensure fork progression and stability and prevent DNA damage checkpoint activation.
2007,
Pubmed
Bermejo,
Genome-organizing factors Top2 and Hmo1 prevent chromosome fragility at sites of S phase transcription.
2009,
Pubmed
Blow,
Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs.
1986,
Pubmed
,
Xenbase
Blow,
Replication origins in Xenopus egg extract Are 5-15 kilobases apart and are activated in clusters that fire at different times.
2001,
Pubmed
,
Xenbase
Charvin,
Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases.
2003,
Pubmed
Cornacchia,
Mouse Rif1 is a key regulator of the replication-timing programme in mammalian cells.
2012,
Pubmed
Cuvier,
A role of topoisomerase II in linking DNA replication to chromosome condensation.
2003,
Pubmed
,
Xenbase
Cuvier,
A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition.
2008,
Pubmed
,
Xenbase
Dimitrova,
The spatial position and replication timing of chromosomal domains are both established in early G1 phase.
1999,
Pubmed
,
Xenbase
DiNardo,
DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.
1984,
Pubmed
Gasser,
Metaphase chromosome structure. Involvement of topoisomerase II.
1986,
Pubmed
Germe,
Topoisomerase II-DNA complexes trapped by ICRF-193 perturb chromatin structure.
2005,
Pubmed
,
Xenbase
Hayano,
Rif1 is a global regulator of timing of replication origin firing in fission yeast.
2012,
Pubmed
Hellmann,
Overview and historical development of dexrazoxane.
1998,
Pubmed
Herrick,
Replication fork density increases during DNA synthesis in X. laevis egg extracts.
2000,
Pubmed
,
Xenbase
Hiratani,
Replication timing and transcriptional control: beyond cause and effect--part II.
2009,
Pubmed
Holm,
DNA topoisomerase II is required at the time of mitosis in yeast.
1985,
Pubmed
Huberman,
On the mechanism of DNA replication in mammalian chromosomes.
1968,
Pubmed
Hyrien,
Chromosomal replication initiates and terminates at random sequences but at regular intervals in the ribosomal DNA of Xenopus early embryos.
1993,
Pubmed
,
Xenbase
Hyrien,
Plasmid replication in Xenopus eggs and egg extracts: a 2D gel electrophoretic analysis.
1992,
Pubmed
,
Xenbase
Hyrien,
Topological analysis of plasmid DNA replication intermediates using two-dimensional agarose gels.
2009,
Pubmed
,
Xenbase
Jackson,
Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells.
1998,
Pubmed
Jun,
Persistence length of chromatin determines origin spacing in Xenopus early-embryo DNA replication: quantitative comparisons between theory and experiment.
2004,
Pubmed
,
Xenbase
Knott,
Forkhead transcription factors establish origin timing and long-range clustering in S. cerevisiae.
2012,
Pubmed
Labit,
DNA replication timing is deterministic at the level of chromosomal domains but stochastic at the level of replicons in Xenopus egg extracts.
2008,
Pubmed
,
Xenbase
Labit,
A simple and optimized method of producing silanized surfaces for FISH and replication mapping on combed DNA fibers.
2008,
Pubmed
,
Xenbase
Lemaitre,
Mitotic remodeling of the replicon and chromosome structure.
2005,
Pubmed
,
Xenbase
Lucas,
Topoisomerase II can unlink replicating DNA by precatenane removal.
2001,
Pubmed
,
Xenbase
Luciani,
Characterization of a novel ATR-dependent, Chk1-independent, intra-S-phase checkpoint that suppresses initiation of replication in Xenopus.
2004,
Pubmed
,
Xenbase
Luke,
Quantitation of type II topoisomerase in oocytes and eggs of Xenopus laevis.
1989,
Pubmed
,
Xenbase
Lyu,
Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
2007,
Pubmed
Mahbubani,
DNA replication initiates at multiple sites on plasmid DNA in Xenopus egg extracts.
1992,
Pubmed
,
Xenbase
Mantiero,
Limiting replication initiation factors execute the temporal programme of origin firing in budding yeast.
2011,
Pubmed
Mao,
SUMO-1 conjugation to human DNA topoisomerase II isozymes.
2000,
Pubmed
Marheineke,
Use of DNA combing to study DNA replication in Xenopus and human cell-free systems.
2009,
Pubmed
,
Xenbase
Marheineke,
Control of replication origin density and firing time in Xenopus egg extracts: role of a caffeine-sensitive, ATR-dependent checkpoint.
2004,
Pubmed
,
Xenbase
Marheineke,
Aphidicolin triggers a block to replication origin firing in Xenopus egg extracts.
2001,
Pubmed
,
Xenbase
Matsuno,
The N-terminal noncatalytic region of Xenopus RecQ4 is required for chromatin binding of DNA polymerase alpha in the initiation of DNA replication.
2006,
Pubmed
,
Xenbase
McClendon,
Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks.
2005,
Pubmed
Morris,
Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193.
2000,
Pubmed
Niimi,
Co-localization of chicken DNA topoisomerase IIalpha, but not beta, with sites of DNA replication and possible involvement of a C-terminal region of alpha through its binding to PCNA.
2001,
Pubmed
Nitiss,
DNA topoisomerase II and its growing repertoire of biological functions.
2009,
Pubmed
Nitiss,
Targeting DNA topoisomerase II in cancer chemotherapy.
2009,
Pubmed
Patel,
The Hsk1(Cdc7) replication kinase regulates origin efficiency.
2008,
Pubmed
Paulson,
The structure of histone-depleted metaphase chromosomes.
1977,
Pubmed
Philpott,
Sperm decondensation in Xenopus egg cytoplasm is mediated by nucleoplasmin.
1991,
Pubmed
,
Xenbase
Raghuraman,
Cell cycle-dependent establishment of a late replication program.
1997,
Pubmed
Remus,
DNA topology, not DNA sequence, is a critical determinant for Drosophila ORC-DNA binding.
2004,
Pubmed
Roca,
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
1994,
Pubmed
Roca,
On the simultaneous binding of eukaryotic DNA topoisomerase II to a pair of double-stranded DNA helices.
1993,
Pubmed
Sangrithi,
Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome.
2005,
Pubmed
,
Xenbase
Schvartzman,
A topological view of the replicon.
2004,
Pubmed
Shechter,
ATR and ATM regulate the timing of DNA replication origin firing.
2004,
Pubmed
,
Xenbase
Sørensen,
Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication.
2012,
Pubmed
Takasuga,
ICRF-193, an inhibitor of topoisomerase II, demonstrates that DNA replication in sperm nuclei reconstituted in Xenopus egg extracts does not require chromatin decondensation.
1995,
Pubmed
,
Xenbase
Tanaka,
Origin association of Sld3, Sld7, and Cdc45 proteins is a key step for determination of origin-firing timing.
2011,
Pubmed
Thomae,
Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins.
2008,
Pubmed
Uemura,
Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.
1984,
Pubmed
Walter,
Regulation of replicon size in Xenopus egg extracts.
1997,
Pubmed
,
Xenbase
Wang,
Cellular roles of DNA topoisomerases: a molecular perspective.
2002,
Pubmed
Wong,
Cdc45 limits replicon usage from a low density of preRCs in mammalian cells.
2011,
Pubmed
Woodward,
Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress.
2006,
Pubmed
,
Xenbase
Wu,
Establishing the program of origin firing during S phase in fission Yeast.
2009,
Pubmed
Yamazaki,
Rif1 regulates the replication timing domains on the human genome.
2012,
Pubmed
Yang,
Modeling genome-wide replication kinetics reveals a mechanism for regulation of replication timing.
2010,
Pubmed